Abbott Diabetes Care Inc.

Christopher A Thomas

Udo Hoss

Marc Barry Taub

Tahir Sadik Khan

Steven Scott

Claire Bhogal

Owen D Reynolds

Jean-Pierre Babka

Mark S Yahnke

Bree M Winter

Dharmendra S Patel

Katie A Cranfield

Christopher J Bennell

Phillip Yee

Martin J Fennell

Michael R Love

Lei He

Daniel Milfred Bernstein

Gary Ashley Stafford

Jean-Pierre Cole

Namvar Kiaie

Jeffery Mario Sicurello

Gary Alan Hayter

Mark Kent Sloan

Kenneth J Doniger

Theodore John Kunich

Marc B Taub

Tahir S Kahn

Benjamin Jay Feldman

Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.

Medical devices and methods

Systems, devices, kits, and methods are provided herein in the form of example embodiments that relate to calibration of medical devices. The medical devices can be sensors adapted to sense a biochemical attribute. The embodiments can be used to determine calibration information specific to an individual medical device. The embodiments can determine the calibration information by reference to one or more parameters obtained during manufacturing of the medical device. The embodiments can also determine the calibration information by reference to in vitro testing of the medical devices. The embodiments also apply to systems incorporating those medical devices in their use in the field. Also described are embodiments of modifications to surfaces of sensor substrates, such as through applied radiation and/or the creation of a well, to aid in the placement and/or sizing of a sensor element on the substrate.

Systems, devices, and methods related to the individualized calibration and/or manufacturing of medical devices

Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.

Analyte sensor device

Growing community of inventors

Cheltenham, United Kingdom

Christopher A Thomas